ELI LILLY & Co (LLY) Form 10-Q Quarterly Reports
ELI LILLY & Co (LLY) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LLY
CIK: 59478
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: IN
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerLinda Hill
Audit LocationIndianapolis, Indiana, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D | 2026-10-16 | — | SCHEDULE 13D Filing | 0000059478-26-000095 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0000316011-26-000033 | View SEC Doc Filr Page |
| 3 | 2026-10-08 | 2026-10-08 | FORM 3 | 0000059478-26-000094 | View SEC Doc Filr Page |
| 144 | 2026-10-07 | — | 144 Filing | 0000316011-26-000031 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-21 | FORM 4 | 0001262388-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-21 | FORM 4 | 0000059478-26-000091 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-21 | FORM 4 | 0000059478-26-000089 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-21 | FORM 4 | 0001310215-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2025-09-22 | FORM 4 | 0002032089-26-000004 | View SEC Doc Filr Page |
| 3/A | 2026-09-04 | 2025-11-07 | FORM 3/A | 0002096888-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | FORM 4 | 0001861052-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | FORM 4 | 0001955972-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001262388-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0000059478-26-000087 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0000059478-26-000085 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001310215-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | FORM 4 | 0001786054-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001628280-26-057430 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | FORM 4 | 0000059478-26-000083 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001950047-26-007881 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-07 | FORM 4 | 0001685556-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-08-07 | — | 144 Filing | 0001949846-26-000477 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0000059478-26-000081 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0000059478-26-000077 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-01 | FORM 4 | 0002032089-26-000002 | View SEC Doc Filr Page |